Trevi Therapeutics Inc
Research Trevi Therapeutics Inc (TRVI) on Bullrun: market cap USD 2.65B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTRVI
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 2.65B
- Financial periodFY2025
- Net income-USD 42.76M
- Free cash flow-USD 42.10M
Valuation Snapshot
latest market cap is USD 2.65B.
About Trevi Therapeutics Inc
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough.
Frequently asked questions
What is Trevi Therapeutics Inc's market cap?
Trevi Therapeutics Inc's market capitalization is USD 2.65B.
What does Trevi Therapeutics Inc do?
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough.